USPSTF: Decision to Undergo PSA Screening Should Be Individual

TUESDAY, May 8, 2018 -- The U.S. Preventive Services Task Force (USPSTF) concludes that the decision to undergo periodic prostate-specific antigen (PSA) screening for prostate cancer should be an individual one for men aged 55 to 69 years. These...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news